Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond patient benefit: clinical development in hemophilia.
Auerswald G, Šalek SZ, Benson G, Elezović I, Lambert T, Morfini M, Pasi J, Remor E, Santagostino E, Salaj P, Ljung R. Auerswald G, et al. Among authors: pasi j. Hematology. 2012 Jan;17(1):1-8. doi: 10.1179/102453312X13221316477372. Hematology. 2012. PMID: 22549441 Review.
Factor IX inhibitors and anaphylaxis in hemophilia B.
Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, DiMichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Katz J, Bergmann F, Ljung R, Petrini P, Lusher JM. Warrier I, et al. Among authors: pasi j. J Pediatr Hematol Oncol. 1997 Jan-Feb;19(1):23-7. doi: 10.1097/00043426-199701000-00003. J Pediatr Hematol Oncol. 1997. PMID: 9065715
Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series.
Iorio A, Barbara AM, Makris M, Fischer K, Castaman G, Catarino C, Gilman E, Kavakli K, Lambert T, Lassila R, Lissitchkov T, Mauser-Bunschoten E, Mingot-Castellano ME, Ozdemir N, Pabinger I, Parra R, Pasi J, Peerlinck K, Rauch A, Roussel-Robert V, Serban M, Tagliaferri A, Windyga J, Zanon E. Iorio A, et al. Among authors: pasi j. Haemophilia. 2017 Mar;23(2):255-263. doi: 10.1111/hae.13167. Epub 2017 Feb 15. Haemophilia. 2017. PMID: 28205285 Free article.
Factor IX inhibitors and anaphylaxis in hemophilia B.
Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, DiMichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Katz J, Bergmann F, Ljung R, Petrini P, Lusher JM. Warrier I, et al. Among authors: pasi j. Haemophilia. 1997 Jul;3(3):231-2. doi: 10.1046/j.1365-2516.1997.t01-2-00125.x. Haemophilia. 1997. PMID: 27214816 No abstract available.
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.
Lissitchkov T, Klukowska A, Pasi J, Kessler CM, Klamroth R, Liesner RJ, Belyanskaya L, Walter O, Knaub S, Bichler J, Jansen M, Oldenburg J. Lissitchkov T, et al. Among authors: pasi j. Ther Adv Hematol. 2019 Jun 26;10:2040620719858471. doi: 10.1177/2040620719858471. eCollection 2019. Ther Adv Hematol. 2019. PMID: 31263528 Free PMC article. Review.
Experiences with continuous infusion of recombinant activated factor VII.
Schulman S, d'Oiron R, Martinowitz U, Pasi J, Briquel ME, Mauser-Bunschoten E, Morfini M, Ritchie B, Goudemand J, Lloyd J, McPherson J, Négrier C, Peerlinck K, Petrini P, Tusell J. Schulman S, et al. Among authors: pasi j. Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S97-101. Blood Coagul Fibrinolysis. 1998. PMID: 9819037 Clinical Trial.
Factor IX inhibitors and anaphylaxis in haemophilia B.
Warrier I, Ewenstein BM, Koerper MA, Shapiro A, Key N, Dimichele D, Miller RT, Pasi J, Rivard GE, Sommer SS, Bergmann F, Lusher JM. Warrier I, et al. Among authors: pasi j. Haemophilia. 1996 Oct;2(4):259-60. doi: 10.1111/j.1365-2516.1996.tb00149.x. Haemophilia. 1996. PMID: 27214369 No abstract available.
72 results